Comparison

Telocinobufagin European Partner

Item no. TMO-T4A2462-5mg
Manufacturer TargetMol
CASRN 472-26-4
Amount 5 mg
Quantity options 1mL*10mM(inDMSO) 10 mg 1 mg 25 mg 50 mg 5 mg
Category
Type Molecules
Specific against other
Purity 98.42%
Citations Wu S C , Fu B D , Shen H Q , et al. Telocinobufagin enhances the Th1 immune response and protects against Salmonella typhimurium infection[J]. International Immunopharmacology, 2015, 25(2):353-362.
Smiles [H][C@@]12CC[C@]3(O)C[C@@H](O)CC[C@]3(C)[C@@]1([H])CC[C@]1(C)[C@H](CC[C@]21O)c1ccc(=O)oc1
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias Telobufotoxin, Telocinobufogenin
Shipping Condition Cool pack
Available
Shipping Temperature
cool pack
Storage Conditions
-20°
Molecular Weight
402, 52
Target names or alias
Telobufotoxin , Telocinobufogenin
Description
1. Telocinobufagin (Telobufotoxin) is the major endogenous digitalis-like factor. 2. Telocinobufagin significantly decreases the bacterial burdens in the spleen and prolongs the survival time of FIST-immunized mice challenged with live S. typhimurium. 3. Telocinobufagin has immunomodulatory activity, can enhance a Th1 immune response to control intracellular infections, could be developed as a novel immunotherapeutic agent to treat cancer and other immune-mediated diseases.
Pathways
Others

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 5 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close